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π electron orbital interactionsential enzyme for viral infection. Here, we report an extensive π electron orbital
interaction between four amino acids, W132, M178, F181 and F185, located at the dimeric interface of IN that
is critical for the strand transfer activity alone. Catalysis of nine different mutant IN proteins at these
positions were evaluated. Whereas the 3′-processing activity is predominantly strong, the strand transfer
activity of each enzyme was completely dependent on an intact π electron orbital interaction at the dimeric
interface. Four representative IN mutants were constructed in the context of the infectious NL4.3 HIV-1 viral
clone. Whereas viruses with an intact π electron orbital interaction at the IN dimeric interface replicated
comparable to wild type, viruses containing an abolished π interaction were non-infectious. Q-PCR analysis
of viral DNA forms during viral replication revealed pleiotropic effects of most mutations. We hypothesize
that the π interaction is a critical contact point for the assembly of functional IN multimeric complexes, and
that IN multimerization is required for a functional pre-integration complex. The rational design of small
molecule inhibitors targeting the disruption of this π–π interaction should lead to powerful anti-retroviral
drugs.
© 2008 Elsevier Inc. All rights reserved.Introduction
Viral cDNA integration within the host cell genome is essential for
HIV replication. Once properly inserted, viral protein expression follows
leading to maturation and propagation (Brown, 1997). Integration is
facilitated by the viral protein integrase (IN) through two separate DNA
reaction events. The ﬁrst is 3′-processing, where a dinucleotide is
hydrolytically cleaved off each viral DNA terminus. Cleavage results in
two free 3′ hydroxyl groups used for a subsequent nucleophilic attack in
the second reaction. 3′-processing occurs within the cytosol. Following
this processing step, the IN-viral DNA complex, with a number of both
viral and cellular proteins collectively referred to as the pre-integration
complex (PIC), translocates to the nucleus. Here IN mediates the
insertion of the processed viral DNA product within the host genome,
which is termed strand transfer (Asante-Appiah and Skalka, 1999). IN
reactions can be carried out in vitro using puriﬁed protein, a DNA
substratewith endsmimicking theU3orU5viralDNA termini, andMg2+
or Mn2+ as a cofactor (Bushman and Craigie, 1991).
Full length IN contains 288 amino acids and consists of three
functional domains. The N-terminal domain (residues 1–50) contains a
zinc binding motif consisting of two conserved pairs of histidine and
cysteine residues (Johnson et al., 1986). The binding of zinc enhances INl rights reserved.multimerization (Lee et al., 1997; Zheng et al., 1996). The catalytic core
domain (residues 51–212) iswell conservedand contains three invariant
acidic residues that make up the catalytic triad D,D(35)E motif that is
essential for catalysis (Engelman and Craigie,1992; Kulkoskyet al.,1992;
Leavitt et al., 1993). The C-terminal domain (residues 213–288) is much
less evolutionarily conserved compared to the N-terminal and core
domains, and possesses non-speciﬁc DNA binding activity (Khan et al.,
1991; Vink et al., 1993; Woerner and Marcus-Sekura, 1993).
IN is known to function as a multimer. Early information provided
by complementation studies showed that when N-terminal deletion
IN proteins are mixed with C-terminal deletion IN mutants, which
alone are non-functional, the catalytic activity of the protein is
restored to near wild type (WT) levels (Engelman et al., 1993; van Gent
et al., 1993), showing that IN functions at the very least as a dimeric
species. Current models and experimental evidence on retroviral IN
composition indicate that a dimeric species may be sufﬁcient for 3′-
processing, but a tetrameric arrangement, stabilized through DNA
binding at the dimer–dimer interface, is necessary for the integration
process and more relevant to the in vivo nucleo-protein complex (Bao
et al., 2003; Karki et al., 2004). Correspondingly a recent ﬂuorescence
anisotropy study concluded that the HIV-1 IN dimer at the viral DNA
extremities was the most proﬁcient oligomeric species for 3′-
processing, whereas a dimer of dimers was the predominant species
for full integration, or strand transfer (Guiot et al., 2006).
Non-covalent chemical interactions involving aromatic rings are
highly prevalent in intermolecular protein structures and contribute
Fig. 1. The four-tiered aromatic interaction at the IN dimeric interface is critical for
strand transfer catalysis. (A) Aromatic interaction betweenM178, W132, F181, and F185
at the dimeric interface (PDB 2B4J). Monomer A shown in yellow, monomer B in
magenta; amino acid residues shown in stick representation, with atom colors: C
(green), N (blue), and S (orange). (B) Relative activities of IN mutants using unprocessed
21-mer and (C) pre-processed 19-mer starting DNA substrate. STP refers to strand
transfer products. (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article).
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ment of higher ordered oligomeric species. Aromatic ring interactions
predominantly conform to three different orientations; a T-shaped
edge-to-face orientation with an average distance of 4.96 Å, a parallel
displaced stacking arrangement with an average distance of 3.5 Å, and
ﬁnally a face-to-face stacking arrangementwith an average distance of
3.5 Å. The interaction energy of aromatic–aromatic interaction is
much weaker than hydrogen bonds (−4.78 kcal/mol), with the
estimated stabilization energy of an aromatic–aromatic interaction
in an α-helical secondary structure to be −0.8 kcal/mol (Meyer et al.,
2003). The divalent sulfur atom of methionine residues also adopts a
favored orientation when interacting with an aromatic face, and
sulfhydryl–aromatic interactions have emerged as an authentic
chemical interaction present in multiple protein examples. Sulfhy-
dryl–aromatic interactions have an average distance of 3.7 Å (Pal and
Chakrabarti, 2001), and have an estimated stabilization energy of
−0.65 kcal/mol in an α-helical secondary structure (Waters, 2004). It
is estimated that ~60% of aromatic residues (W, Y, and F) present in
proteins are involved in π electron orbital interactions, with the T-
shape edge-to-face and the parallel displaced stacking orientations
being the most prevalent (Meyer et al., 2003). Although the energy
contribution of the aromatic interaction is far weaker than the
hydrogen bond in protein structure, these interactions have been
recognized as playing an important role in overall protein stability.
The involvementofπ electronaromatic interactions in amultitudeof
ligand–receptor contactsmakes it increasingly important to understand
these chemical interactions in more detail. Knowledge gained would
better equip medicinal chemists in lead optimization and drug design
targeting therapeutic protein sites containing aromatic residues found
to be essential for enzymatic function. Previously, we identiﬁed an
allosteric binding site for an HIV-1 IN inhibitor located at the dimeric
interface (Al-Mawsawi et al., 2006). The presence of an aromatic
interaction at the site was shown to be crucial for efﬁcient inhibition of
the enzyme by the small molecule. Here we have examined the π
electron orbital interaction in more detail, and found it contains four
different residues at the dimeric interface, and is absolutely indis-
pensable for the strand transfer activity of the enzyme and is essential
for viral replication. To our knowledge this is the ﬁrst report of an
internal non-covalent π electron interaction as being vital to the
enzymatic function of a retroviral IN protein. This is also the ﬁrst
evidence identifying amino acid residues far removed from the INactive
site that are critical for only one enzymatic function of the enzyme
(strand transfer process), thus indirectly un-coupling the successive
nature of the IN reaction. Previous studies have reported that INproteins
containing an Asp substitution at the Rous Sarcoma Virus IN position
S124 (and the analogous S119HIV-1 INposition) is severely defective for
strand transfer catalysis, while increasing 3′-processing speciﬁcity
(Konsavage et al., 2005; Konsavage et al., 2007). The serine position
reported previously is directly adjacent to the DD(35)E catalytic triad.
Here, we report a π electron orbital interaction at the IN dimeric
interface, distant from the IN catalytic site, that is also required for
strand transfer. Small molecules designed to disrupt this π electron
orbital interaction should be effective allosteric binding IN inhibitors.
We hypothesize that the non-covalent interaction identiﬁed here is a
fundamental contact point in the assembly of fully functional HIV-1 IN
multimers, which in turn is required for proper PIC formation and
function.
Results
π electron orbital interaction at IN dimeric interface is required for
strand transfer catalysis
Depicted in Fig. 1A is the four-tiered π electron orbital interaction
at the dimeric interface. It involves residues M178, F181, and F185
from chain A, and residue W132 from chain B. The ﬁgure shown is amodiﬁed version of the cocrystal structure of the binding domains
between LEDGF/p75 and IN (PDB 2B4J) (Cherepanov et al., 2005), with
attention focused at the IN dimeric interface to emphasize the π
357L.Q. Al-Mawsawi et al. / Virology 377 (2008) 355–363interaction. Analysis of the non-covalent interaction reveals the
sulfhydryl–aromatic distance betweenM178–W132 is 4.13 Å (shortest
distance between S atom and ring center). The remaining interactions
all appear to be variations of the T-shaped edge-to-face orientation
upon visual inspection. The distance between the remaining interac-
tions is 4.76 Å for W132–F181, and 5.65 Å for F181–F185 (shortest
distance between edge–face). The interaction free enthalpy of the
entire π electron orbital network is about −2.25 kcal/mol, or half the
amount of a typical hydrogen bond, when treating the energy
contribution of each interaction separately and assuming the affects
are additive. It is important to note that all IN crystal structures
containing the catalytic core domainwe have examined have the non-
covalent aromatic interaction at the dimeric interface in the same
relative conformation, with the exception of F185. All existing IN
crystal structures with the core domain present have F185 substituted
for either lysine or histidine. IN proteins with the F185K or F185H
substitution have been shown to be more soluble and therefore
enhance the crystallization of the protein without affecting enzymatic
activity (Jenkins et al., 1995). The crystal structure used here contained
the F185K substitution. To generate Fig. 1A, we used the mutagenesis
function in the molecular viewing program PYMOL (W. L. DeLano,
www.pymol.org) to revert position 185 back to phenylalanine.
All mutant IN proteins used in this study were synthesized in the
context of WT IN. Table 1 lists the activities of each mutant relative
to WT, whereas a representative gel depicting the enzymatic activities
of each protein is shown in Fig. 1B. Protein concentrations of each IN
enzyme were determined prior to enzymatic assays to ensure equal
loading and reliable functional comparisons. A clear speciﬁcity for
a cohesive chemical interaction between these residues for the strand
transfer process was observed. The substitutions generated at these
four positions did not signiﬁcantly affect IN 3′-processing activity, with
the exception of M178C and F181G. The M178C mutant exhibited
diminished 3′-processing activity (~30% of WT), whereas the protein
containing a glycine substitution at position F181 showed a moderate
decrease for this activity (~60% of WT). Interestingly, all the π electron
orbital interaction mutants displayed an increase in 20-mer cleavage
product (from 22% to 84%) as compared to WT. Three of the non-
conservative substituted mutants additionally displayed an increase in
18-mer cleavage product (W132G: 88%, W132Y: 13%, and F185G: 12%)
as compared toWT. This suggests residue substitutions in theπ electron
orbital interaction, both conservative and non-conservative, also
inﬂuence the mechanics and/or regulation of 3′-processing. However,
none of the IN mutants displayed a series of cleavage products below
this size giving a clear indication that the phenomenon was not the
result of bacterial exonuclease contamination that originated during
recombinant protein puriﬁcation. Additionally, the inhibitory effects of
a LEDGF/p75 derived peptide displayed a propensity to inhibit both
the classical 19-mer and aberrant 18-mer cleavage products, providing
further evidence this is an IN-mediated 3′-processing irregularity (Al-
Mawsawi et al., 2008). As for the strand transfer activity of themutants,
a strong dependence on the π electron orbital interaction was evi-
denced. For W132, the only residue involved in the interaction fromTable 1
Relative activities of integrase proteins
IN protein 3′-processing Strand transfer
WT +++a +++
W132G +++ –
W132Y +++ –
W132F +++ +++
M178C + –
F181G ++ –
F181Y +++ +++
F185G +++ –
F185Y +++ +++
a Activity designation relative to wild type: –, 0–10%; +, 10–40%; ++, 40-80%;+++,
80-100%.chain B, a substitution to either glycine or tyrosine abolished the strand
transfer catalysis of these mutant proteins. The only substitution to
restore IN strand transfer activity at this position is phenylalanine. We
also generated a lysine substitution at this position. W132K mutant
proteins exhibited diminished 3′-processing capabilitieswith no strand
transfer activity (data not shown). Based on the literature that
sulfhydryl groups can interact favorably with aromatic rings, we
included M178 in our analysis to determine if this residue could be
involved in the proposed π aromatic interaction. Substituting a cysteine
residue at this position created the most catalytically weak protein
under study. As discussed, 3′-processing activity of this mutant was
drastically reduced. The protein did not retain the ability to catalyze
strand transfer. With regards to IN proteins containing substitutions at
position F181, a non-conservative glycine substitution abolished strand
transfer activity, whereas the conservative tyrosine substitution, where
aromaticity is retained, restored this enzymatic function. Similarly, the
mutant F185G did not retain strand transfer catalysis, whereas F185Y
catalyzed this process efﬁciently. All mutants that retained strand
transfer enzymatic function catalyzed this process comparably to WT.
IN reactions are successive in nature, with strand transfer activity
dependent on prior 3′-processing catalysis. It is possible that our π
electron orbital interaction deﬁcient mutants, with the ability to
catalyze 3′-processing but not strand transfer, could be deﬁcient at a
point immediately following 3′-processing before strand transfer
catalysis. This would suggest that these mutants were ‘locked’ in a
post-3′-processing catalytic conformation, and therefore unable to
proceed towards strand transfer catalysis. To directly address at which
catalytic point these mutants are deﬁcient in the IN enzymatic
process, we tested their function using a 3′-processed oligonucleotide
substrate. A gel depicting the activity of each IN protein using this
processed substrate is shown in Fig. 1C. The strand transfer catalytic
proﬁle of all IN proteins using this processed substrate was identical to
the unprocessed DNA substrate. This result indicates that IN proteins
containing a disrupted π aromatic interaction are deﬁcient only for
strand transfer activity. The π electron orbital interaction between
residuesW132, M178, F181, and F185 represents an ideal allosteric site
for the design of strand transfer-speciﬁc small molecule IN inhibitors.
Aromaticity at position W132 is conserved among lentiviruses
Considering the proposed role of the π aromatic interaction for IN
catalysis, we sought to determine the evolutionary importance of the
four residues in a conservation sequence alignment. Eight lentiviral IN
protein sequences were compared to the HIV-1 WT IN protein
sequence. Also included in the alignment were three retroviral IN
proteins of a different genus: human T-cell lymphotropic virus type 1
(Deltaretrovirus), Rous sarcoma virus (Alpharetrovirus), and Moloney
murine leukemia virus (Gammaretrovirus). The results of the align-
ment are shown in Fig. 2. None of the four residues are absolutely
conserved. At the position corresponding to W132 of HIV-1 however,
aromaticity is completely conserved for lentiviral IN proteins.
Viruses containing an abolished π electron orbital interaction at the IN
dimeric interface are non-infectious
To investigate the π interaction further, we constructed four
representative IN mutants in the context of the infectious NL4.3 HIV-1
viral clone, i.e. NL4.3 M178C, F181G, F181Y and F185G. The mutant
molecular clones were examined for their ability to replicate in MT-4
cells. Whereas the mutant virus containing an intact π electron orbital
interaction at the IN dimeric interface (NL4.3 F181Y) replicated
comparable to wild type, viruses containing an abolished π electron
orbital interaction at the IN dimeric interface were non-infectious
(NL4.3 M178C, F181G and F185G) (Fig. 3A).
To determine the step at which the replication cycle of these
viruses is affected, real-time quantitative PCR analysis was performed
Fig. 2. Aromaticity at position W132 (HIV-1) is conserved in lentiviral IN proteins. In sequence alignment, highly conserved is depicted with black background with residues listed in
white, while moderately conserved is shown in grey background with black lettering. ‘125’ refers to starting position for HIV-1 IN protein sequence. W132 labeled with arrow; M178,
F181, and F185 labeled with asterisk.
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during infection. DNA was extracted at several time points post-
infection. As expected, the replication-competent virus with a
conservative tyrosine substitution at position F181 (that retains
aromaticity) displayed similar levels of early total cDNA, 2-LTR circles
and integrated proviruses as compared toWT HIV-1 (Figs. 3B,C,D). The
three other mutants affected the accumulation of viral cDNA at early
time points. The smallest effect was seen with the F185G mutant,
whereas the strongest defect was observed for the M178C and the
F181G mutants (Fig. 3B). All replication-incompetent viruses showedFig. 3. Analysis of mutant HIV-1 virus replication. (A) MT-4 cells were inoculated with wild t
(▲) NL4.3 F181G, (Δ) NL4.3 F181Y and (□) NL4.3 F185G. The replication kinetics were determ
post-infection. Experiments were performed at least twice. Quantiﬁcations were performed
forms during replication. MT-4 cells were infected with WT or mutant HIV-1 at an MOI of 0
real-time PCR. Late reverse transcripts were quantiﬁed 6 h post-infection (B), and 2-LTR
performed at least twice. Quantiﬁcations were performed in duplicate and averages±SD arundetectable levels of 2-LTR circles and integrated proviral DNA in
comparison to WT virus (Figs. 3C,D).
Model map of non-covalent interactions at the IN dimeric interface
Most protein–protein interfaces are characterized by smaller
complementary pockets of either a hydrophobic nature or with
buried hydrophilic charged residues forming salt bridges across the
interface which are critical for the overall interaction (Moreira et al.,
2007). To examine other possible interactions at the dimeric interfaceype or mutant viruses corresponding to 25 pg/mL p24: (⁎) WT NL4.3, (◊) NL4.3 M178C,
ined by measuring viral p24 antigen levels in the supernatant at different time points
in duplicate and averages±SD are shown. (B–C–D) Effects of mutations on viral DNA
.1. At different time points after infection, DNA extracts were prepared and analyzed by
circles (C) and integrated proviral DNA at 72 h post-infection (D). Experiments were
e shown.
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the catalytic core dimeric interface of IN using available crystal
structures (Fig. 4A). Also depicted (Fig. 4B) is the protein sequence
alignment discussed earlier spanning the other dimeric interface
contacts we identiﬁed. The aromatic system between M178, W132,
F181, and F185 is located at both horizontal extremes of the interface.
We have also located another aromatic four-tiered interaction
between W61 and W108, of chain A, which interacts with a corres-
ponding W108 and W61 of chain B. The four tryptophan sidechains
are each in the T-shaped edge-to-face orientation. The distance
between each Trp is 4.54 Å for W61 (chain A)–W108 (chain A), 4.42 Å
for W108 (chain A)–W108 (chain B), and 4.54 Å for W108 (chain B)–
W61 (chain B) (shortest distance between edge–face). The interaction
free enthalpy of the entire W61–W108 π electron orbital network to is
about −2.4 kcal/mol, or half the amount of a typical hydrogen bond,
when treating the energy contribution of each interaction separately
and assuming the affects are additive. W61 is completely conserved in
all the retroviral IN proteins included in our sequence alignment. A
W61R substitution generated in both HIV-2 IN (van den Ent et al.,
1998) and the Avian leukemia and sarcoma virus IN (Moreau et al.,
2002) created a highly insoluble protein suggestive of defects in
oligomerization. Indeed the aromatic interaction deﬁcient mutants
studied herewere also more difﬁcult to purify compared to INproteins
where the aromatic interaction was intact. At position W108, all the
lentiviral IN proteins contain a residue capable of aromatic interaction.
We have also located two highly charged symmetrical centers at the
interface, one between E87 and K103, and the other between E85 andFig. 4. IN catalytic core dimeric interface has four critical contact points, two aromatic and tw
between monomers. Residues frommonomer A shown in yellow, monomer B in magenta; al
178, 181, and 185. Dimeric interface runs perpendicular to the plane of view. (B) Sequence alig
to starting position for HIV-1 IN protein sequence. Amino acid pairs are denoted: W61 andW
in this ﬁgure legend, the reader is referred to the web version of this article)R107. Complimentary residues across an interface often co-evolve (Goh
and Cohen, 2002), and salt bridge linkages are a common characteristic
at protein–protein interfaces. When analyzing the sequence alignment
these pairs of residues are highly correlated suggesting a distinct
interaction. For each IN protein containing a glutamic acid residue at
position 87 (corresponding to HIV-1), a positive residue (K or H) is
located at the position corresponding to 103 of HIV-1 IN. A similar
linkage can be observed for the E85 and R107 pair. It is difﬁcult to
determine how much stability these symmetrically placed pair of salt
bridges may contribute to IN dimeric stability. A previous study
examined the energetic contribution of two symmetrically placed Lys–
Asp salt bridges using a homodimeric hemoglobin protein. It was
determined that disruption of the chargedpairs, providedbya Lys toAsp
substitution, in combination with subsequent water hydration at the
interface, disrupted dimeric stability by 8 kcal/mol (Ceci et al., 2002).
Mutagenic studies conducted in HIV-2 IN found an E85W substitution
did not affect function (van den Ent et al., 1998), however this
substitution would create two closely-spaced cationic–π interactions,
with eachbeing energetically favorable by −0.4 kcal/mol (Waters, 2004).
Conversely, both an E87Q and R107A substitution in HIV-2 INwere also
reported as being catalytically active (vanden Ent et al.,1998), indicating
the symmetrical charged centersmayonlycontribute aminor fraction to
overall dimeric stability and are not as prominent a factor as the
sequence alignment suggests.
Compilation and analysis of available alanine-scanning data on
protein–protein interfaces show that 93% of residues that result in a
change of overall free energy of binding higher than 4 kcal/molo charged. (A) Model map of the IN dimeric interface highlighting critical contact points
l residues shown in stick representationwith electron orbital depiction for residues 132,
nment spanning IN region that contains other putative dimeric contact points; 55 refers
108 (⁎), E85 and R107 (T), E87 and K103 (#). (For interpretation of the references to color
360 L.Q. Al-Mawsawi et al. / Virology 377 (2008) 355–363followingmutagenesis reside in complementary pockets (Keskin et al.,
2005). If the energy of each π electron orbital interaction is considered
as strong as the summation of bond strength, and each charged center
is treated as aweak complementary pocket, it can be estimated that in
combination these networks provide at least −10 kcal/mol in
stabilization energy to the IN catalytic core domain dimer.
Discussion
We have located a π electron aromatic interaction between four
residues at the dimeric interface of IN that is indispensable for strand
transfer catalysis. Substitutions that disrupt this interaction abolished
strand transfer activity with lesser effects on 3′-processing. The addition
of other metal cofactors (Ca2+ and Zn2+) in the reaction buffer does not
restore strand transfer activity to the aromatic interaction deﬁcient
mutants as previously shown (Al-Mawsawi et al., 2006). W132 was the
only residue from chain B involved in the aromatic interaction.
Previously, we showed that W132 was critical for inhibition of a group
of hydroxycoumarin IN inhibitors. Non-conservative substitutions (A, G,
and R) decreased the potency of these molecules selectively, whereas a
conservative tyrosine substitution, restoring the aromatic interaction,
enabled the coumarins to bind correctly for optimal inhibition (Al-
Mawsawi et al., 2006). All amino acid substitutions in this prior study
were generated in the context of an IN double mutant (F185 K/C280S)
that is known to promote solubility of the enzyme without affecting
enzymatic activity in vitro (Jenkins et al., 1996). Here we generated all
mutants in the context of WT IN. When we again generated the non-
conservative glycine substitution at position W132 in the WT context,
strand transfer activity was abolished as seen previously. Unexpectedly,
whenwe generated the conservative W132Y substitution in the context
of WT, strand transfer activity of the enzyme was also abolished. This
prompted us to investigate the role of F185 within the aromatic
interaction. It appears that thepresence of F185K (soluble doublemutant
F185K/C280S) creates an environment at position W132 that is more
tolerable, enabling a tyrosine to restore the aromatic interaction and
therefore strand transfer catalysis. This is not entirely surprising
considering single π aromatic interactions are often observed within
larger cohesive π interactions within proteins (Meyer et al., 2003). The
presence of a cationic element at one end of the aromatic interaction
would have deﬁnite inﬂuence on the entire π aromatic system. In the
context of WT IN, phenylalanine was the only substitution at W132 that
could restore strand transfer activity to IN. W132, being the only residue
from chain B in the interaction, seems to have a unique role in this
aromatic system. The tryptophan residue at position 132 makes two
contacts that bridge the dimeric interface. It is not presently clear if the
sulfhydryl–aromatic interaction between M178–W132, as compared
with theπ edge-face interactionwithW132–F181, play equal roles in this
chemical system. W132 has also been implicated in one hotspot of
interactionbetween the IN cellularcofactor LEDGF/p75, elucidatedby the
recent cocrystal structure and mutagenesis studies (Busschots et al.,
2007; Cherepanov et al., 2005). Previously, an alanine substitution at
W132 was shown to disrupt the LEDGF/p75-IN interaction (Busschots
et al., 2007) and viruses harboring the IN W132A enzyme were repli-
cation defective due to a speciﬁc block in integration (Rahman et al.,
2007). M178 was also observed in this contact point with LEDGF/p75.
Making a conservative cysteine substitution at this position, where a
sulfhydryl group was retained, created the most enzymatically compro-
mised IN protein under study. It is possible that the addition of a
hydrogen bond donor group (–SH) disrupted the sulfhydryl–aromatic
interaction with W132. W132Y, with the phenyl linked hydrogen bond
donor hydroxyl group, may have caused a similar sulfhydryl–aromatic
disruption in the context of WT. To our knowledge, F181 has not been
implicated in any IN process. Making a non-conservative glycine sub-
stitution at this position abolished strand transfer activity of the enzyme.
Catalytic activity was restored with a conservative tyrosine substitution.
Residue F185 followed a similar pattern as F181. A glycine substitutionabolished strand transfer activity of the protein, whereas the mutant
F185Y was fully active. Many studies have documented the strong
enzymatic activity of IN proteins carrying F185K or F185H substitutions.
It appears the π electron orbital interaction we have identiﬁed can
tolerate either a histidine or lysine residue at position F185. Both these
residues are highly capable of interacting in energetically favorable
chemical aromatic systems (BurleyandPetsko,1985). Lysineandarginine
residues have been well documented to make favorable cationic–π
interactions with aromatic residues (Gallivan and Dougherty, 1999; Ma
and Dougherty, 1997). Considering this leniency at position F185, we
constructed W132K substitutions in both WT and the soluble double
mutant (F185K/C280S). Both these proteins were severely hampered in
3′-processing activity and strand transfer catalysis was abolished (data
not shown). Our observations indicate that substitution of cationic
character can be tolerated at one end of the four-tiered aromatic system
(F185), but not within the center of this interaction (W132).
To investigate theπ interaction further, four IN substitutions (M178C,
F181G, F181Yand F185G) were introduced in the infectious NL4.3 HIV-1
viral clone. Only the F181Y virus was replication-competent. All viruses
containing an abolished π electron orbital interaction were non-
infectious (Fig. 3A). Although these mutants mostly affect strand
transfer activity in vitro, all virus mutants displayed pleiotropic effects
in cellulo. M178C and F181G, but not F185G, signiﬁcantly affected viral
cDNA formation at 6 h post-infection (Fig. 3B). With the exception of
F181Y, none of the IN-mutant-viral strains generated 2-LTR circles or
integrated viral DNA to measurable levels. Reverse transcription and
integration are coupled and partially synchronous during retroviral
replication. In the pre-integration complex (PIC), IN binds to the ﬁrst
fragment of cDNA, well before the reverse transcription process is
completed. A functional interaction between reverse transcriptase (RT)
and IN has also been demonstrated (Wu et al.,1999), and C130S (residue
adjacent toπ interaction) IN-viral strains are defective in the initiation of
endogenous reverse transcription (Zhu et al., 2004). We hypothesize
that the π interaction is a critical interface for the assembly of fully
functionalmultimeric complexes of IN, which furthermay be important
for RT interactions and/or PIC stability. After 3′-processing, the PIC is
transported to thenucleus,where theviral cDNA is integrated in thehost
DNA or non-productive 2-LTR circles are formed. 2-LTR circles are thus
an indirectmeasure for nuclear import. The lack of nuclear import of our
π interaction deﬁcient IN mutants suggests that nuclear import of the
PIC will only occur in the context of fully functional multimeric
complexes of IN. Alternatively, erroneous 3′-processing by the mutant
enzymes, as suggested by the appearance of alternative 20-mer cleavage
products (Fig. 1B), may also interfere with the functionality of the PIC.
The association between the cellular cofactor LEDGF/p75 and IN is
lentivirus-speciﬁc (Busschots et al., 2005). Here we have conducted a
sequence alignment using 9 lentiviral IN protein sequences and the IN
protein sequences from the three genuses observed not to interact
with LEDGF/p75. At the position corresponding to W132 in HIV-1,
aromaticity was completely conserved in lentiviral IN proteins, but not
the IN proteins from alpha-, delta-, or gamma-retroviruses. The
aromatic feature at this position may be a key element for lentiviral
speciﬁcity of the LEDGF/p75-IN interaction. Also striking is that full
length LEDGF/p75 protein binds to the area surrounding the four-
tiered π electron orbital interaction and stimulates strand transfer
activity, whereas our mutagenic study shows that the loss of this non-
covalent interaction abolishes strand transfer activity. It has also been
demonstrated that the overexpression of the IN binding domain of
LEDGF/p75 inhibits viral replication (De Rijck et al., 2006) and this
truncated version of LEDGF/p75 can not stimulate IN strand transfer
catalysis like the full length protein (Cherepanov et al., 2004). The
correlation between these phenomena is not presently clear, and may
become apparent in future studies that incorporate substrate DNA in
this nucleo-protein complex to give amore global mechanistic picture.
Recent studies suggest that an INdimer is sufﬁcient for 3′-processing,
but a tetrameric arrangement, possibly stabilized by DNA substrate,
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2006; Karki et al., 2004). We have uncovered amino acid residues that
are critical for strand transfer catalysis, but not 3′-processing. The π
electron orbital network between M178, W132, F181, and F185, when
intact, facilitates strand transfer catalysis. This suggests that the four-
tiered π electron system is a critical pre-requisite for tetramerization of
IN. It is possible that an intact aromatic system at this position
helps stabilize the DNA substrate promoting IN tetramerization in
order for strand transfer catalysis to proceed. Our results also indicate
this process is required by RT function and/or PIC stability in the viral life
cycle.
In conclusion, we have identiﬁed an extensive π electron orbital
interaction at the dimeric interface of IN that involves bothmonomers,
is four-tiered and includes residues M178, W132, F181, and F185.
Viruses containing an abolished π electron orbital interaction at the IN
dimeric interface were non-infectious. We hypothesize that the π
interaction is a critical contact point for the assembly of fully functional
multimeric complexes of IN, which is further required for strand
transfer, RT function and/or PIC formation and function. Rationally
designed small molecules targeting this four-tiered π electron system
could provide powerful drugs for the treatment of HIV/AIDS.
Materials and methods
Site directed mutagenesis
Site directed mutagenesis was conducted on the pET-15b-IN
plasmid, containing the WT sequence, a generous gift from Dr. Robert
Craigie, Laboratory of Molecular Biology, NIDDK, NIH, Bethesda, MD.
The plasmid contains full length IN fused to a 6-residue N-terminal
histidine tag downstream from a T7 promoter. The Quickchange site-
directedmutagenesis kit (Stratagene) was employed tomake the point
mutations according to the manufacturer's instructions. The oligonu-
cleotide primers for each additional mutant are as follows, with the
substituted nucleotide(s) shown in boldface and the mutated codon
underlined.M178C: sense, 5′-GCTGAACAT CTTAAGACAGCAGTACAA
TGC GCA GTA TTC ATC CAC-3′; antisense, 5′-GTG GAT GAA TAC TGC
GCA TTG TAC TGC TGT CTT AAG ATG TTC AGC-3′. W132F: sense, 5′-CC
GCCTGT TGGTTCGCGGGGATCAAGCAGG-3′; antisense, 5′-C CTGCTT
GATCCCCGCGAACCAACAGGCGG-3′.W132G: sense, 5′-GCC TGT TGG
GGG GCG GGG ATC AAG CAG G-3′; antisense, 5′-C CTG CTT GAT CCC
CGC CCC CCA ACA GGC-3′. W132K: sense, 5′-GCC GCC TGT TGG AAG
GCGGGGATCAAGCAGG-3′; antisense, 5′-C CTGCTTGAT CCCCGCCTT
CCA ACA GGC GGC-3′. W132Y: sense, 5′-GCC GCC TGT TGG TAC GCG
GGGATCAAGCAGG-3′; antisense, 5′-C CTGCTTGAT CCCCGCGTACCA
ACA GGC GGC-3′. F181G: sense, 5′-GCA GTA CAA ATG GCA GTA GGC
ATC CACAAT TTTAAAAGAAAAGGG-3′; antisense, 5′-CCC TTT TCT TTT
AAA ATT GTG GAT GCC TAC TGC CAT TTG TAC TGC-3′. F181Y: sense, 5′-
GCAGTA CAA ATG GCA GTA TAC ATC CAC AAT TTT AAA AGA AAAGGG-
3′; antisense, 5′-CCC TTT TCT TTT AAA ATT GTG GAT GTA TAC TGC CAT
TTG TAC TGC-3′. F185G: sense, 5′-G GCA GTA TTC ATC CAC AAT GGT
AAAAGAAAAGGGGGGATTG-3′; antisense, 5′-C AAT CCCCCC TTT TCT
TTT ACC ATT GTG GAT GAA TAC TGC C-3′. F185Y: sense, 5′-G GCA GTA
TTCATC CACAAT TATAAAAGAAAAGGGGGGATTG-3′; antisense, 5′-C
AAT CCC CCC TTT TCT TTT ATA ATT GTG GAT GAA TAC TGC C-3′.
Nucleotide replacements were conﬁrmed by sequencing at the USC/
Norris Comprehensive Cancer Center Microchemical Core Facility
(University of Southern California).
Expression and puriﬁcation of recombinant HIV-1 IN
The IN plasmid was expressed in Escherichia coli BL21(De3) PLYS S
expression strain (Invitrogen) after induction by IPTG (1 mM) at an
absorbance of 0.6–0.8 optical density at 595 nm. The culture was
allowed to grow for an additional 3–4 h. at 37 °C. This was followed by
centrifugation of the cells, at 3000 rpm in a bucket rotor centrifuge(Beckman) for 20 min. Pelleted cells were resuspended in lysis buffer
(20 mM HEPES, pH 7.5, 5 mM imidazole, 100 mM NaCl) and passed
twice through a French Press (Thermo Spectronic). Lysate was
centrifuged at 31,000 g and the pellet was solubilized in a buffer
containing 20 mMHEPES, pH 7.5, 5 mM imidazole, and 10mM CHAPS.
The IN proteinwas puriﬁed using Ni-afﬁnity chromatography with Ni-
NTA agarose beads (Qiagen), with increasing concentrations of
imidazole used to elute the protein. Imidazole fractions were
collected, and aliquots of each were separated on an SDS-PAGE gel
and stained with Coomassie blue dye. Fractions containing IN protein
were dialyzed in Spectra/Por molecular porous membrane tubing,
MWCO 12–14,000 (Spectrum Laboratories, Inc.), suspended in a buffer
containing 20 mM HEPES, pH 7.5, 500 mM NaCl, 40% glycerol, 0.2 mM
EDTA, and 1 mM dithiothreitol (DTT). After dialysis, the puriﬁed
enzyme solution contained 50 mM NaCl, 1 mM HEPES, pH 7.5, 50 μM
EDTA, 50 μM DTT, and 10% glycerol (w/v).
Oligonucleotide substrates and IN enzymatic assays
Oligonucleotide substrates mimicking the HIV-1 U5 LTR DNA
termini, 19-mer top strand (5′-GTGTGGAAAATCTCTAGCA-3′), 21-mer
top strand (5′-GTGTGGAAAATCTCTAGCAGT-3′) and 21-mer bottom
strand (5′-ACTGCTAGAGATTTTCCACAC-3′), were purchased fromUSC/
Norris Comprehensive Cancer Center Microchemical Core Facility
(University of Southern California) and puriﬁed by UV shadowing on
polyacrylamide gel. In order to analyze the amount of both DNA
reaction events, the 21-mer top oligonucleotide was 5′-end-labeled
using T4 polynucleotide kinase (Epicenter, Madison, WI) and γ-[32P]
ATP (MP Biomedicals, Irvine, CA). Afterwards the kinase was heat
inactivated, and the 21-mer bottom oligonucleotide was added in
1.5 molar excess. The sample was then heated to 95 °C, cooled slowly,
and subsequently passed through a G-25 Sephadex spin column (USA
Scientiﬁc) to remove any unincorporated material from the annealed
double-stranded oligonucleotide.
IN enzymatic assays for WT and each mutant followed the same
general procedure. To determine the extent on both 3′-processing and
strand transfer catalytic activities, puriﬁed IN enzyme (ﬁnal concen-
tration: 200 nM) was added to a reaction buffer [7.5 mM MnCl2,
0.1 mg/mL bovine serum albumin, 10 mM β-mercaptoethanol, and
25 mMMOPS, pH 7.2] followed by the addition of 20 nM of the 5′-end
32P-labeled linear double-stranded oligonucleotide, and the reaction
mixture was incubated for 1 h at 30 °C. Upon completion the sample
reactions were quenched by adding half the total volume (8 μL) of
loading dye (98% deionized formamide, 10 mM EDTA, 0.025% xylene
cyanol, and 0.025% bromophenol blue). A sample aliquot was
electrophoresed on a denaturing 20% polyacrylamide gel (0.09 M
Tris–borate, pH 8.3, 2 mM EDTA, 20% acrylamide, and 8 M urea). Gels
were vacuum dried, exposed in a PhosphorImager cassette, analyzed
using a Typhoon 8610 Variable Mode Imager (Amersham Biosciences),
and quantiﬁed using ImageQuant 5.2.
Viral integrase alignment
The protein sequence for HIV-1 IN was obtained through direct
translation of the wild type sequence expressed in the pET-15b-IN
plasmid used in this study. All remaining integrase protein sequences
from the Retroviridae family were obtained directly from the Retro-
viruses Homepage located at the National Center for Biotechnology
Information (NCBI) database (http://www.ncbi.nlm.nih.gov/retro-
viruses/). The accession number for each species, following their
respective genus is as follows: Lentivirus; SHIV (AAL78990), SIV
(AAK97265), HIV-2 (AAC95341), FIV (NP040973), BIV (P19561), Caprine
Arthritus Encephalitus Virus (P33459), Visna-Maedi Virus (AAM51650),
and Equine Infectious Anemia Virus (NP056902). Deltaretrovirus;
Human T-Cell Lymphotropic Virus-1 (P14708), Alpharetrovirus; Rous
Sarcoma Virus (Q04095), Gammaretrovirus; Moloney Murine Leukemia
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the multiple alignment software CLUSTAL W (Thompson et al., 1994)
and exported in the boxshade results format.
Virus strains
The HIV-1 molecular clone pNL4.3 (Adachi et al., 1986) was
obtained through the AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH contributed by Dr. Malcolm Martin
(Bethesda, MD). To generate the M178C, F181G, F181Y and F185G IN
mutated viruses, site-directed mutagenesis was performed using the
Kirsch and Joly method (Kirsch and Joly, 1998). The presence of the
expected mutations was conﬁrmed by DNA sequencing of the entire
IN coding region. Virus productions were performed as described
previously (De Rijck et al., 2006).
Determination of replication capacity of HIV-1 strains
Inoculants of various HIV-1 strains containing equal amounts of
HIV-1 p24 antigen (25, 12.5 and 6.25 pg/mL) were added to MT-4 cells
(50,000 cells/mL). From 3 days post-infection on, aliquots of cell free
supernatants were harvested for the determination of viral p24 levels
(Alliance HIV-1 P24 antigen ELISA Kit, Perkin Elmer Life Sciences,
Milano, Italy).
HIV-1 infection assay
MT-4 cells (2.5×106 cells/well) were incubated with WT HIV-1
NL4.3 or mutant NL4.3 (corresponding to 250 ng of p24). After a 3 h
incubation at 37 °C, the cells were washed with PBS, transferred to
newmedium and seeded in a 24-well plate (ca. 300,000 infected cells/
well). In each 24-well plate, uninfected MT-4 cells were incubated in
parallel. Each time a sample was prepared for Q-PCR analysis, an
aliquot of uninfected cells was prepared as well.
Quantiﬁcation of different HIV-1 DNA species by real-time PCR
A speciﬁcally designed set of TaqManprobe and primerswas used to
quantify the amount of each speciﬁc HIV-1 DNA form in the cell lysate.
For the quantiﬁcation of late reverse transcripts (total HIV-1 DNA), the
forward primer 5′-TGTGTGCCCGTCTGTTGTGT-3′, the reverse primer 5′-
GAGTCCTGCGTCGAGAGAGC-3 ′ , and the probe 5 ′-(FAM)-
CAGTGGCGCCCGAACAGGGA-(TAMRA)-3′ were used (Butler et al.,
2001). For quantiﬁcation of 2-LTR circles, the forward primer: 5′-
GTGCCCGTCTGTTGTGTGACT-3 ′ , the reverse primer: 5 ′-
CTTGTCTTCTTTGGGAGAGAATTAGC-3′ and the probe: 5′-(FAM)-TCCA-
CACTGACTAAAAGGGTCTGAGGGATCTCT-(TAMRA)-3′ were employed.
Ampliﬁcation was as reported previously (Van Maele et al., 2003).
Quantiﬁcation of integrated proviruses (Alu-PCR) was done using a
nested Alu-PCR, modiﬁed from a method described previously
(O'Doherty et al., 2002). The ﬁrst round PCR was performed using the
forward primer 5′-GCTAACTAGGGGAACCCACTGCTTA-3′ and the
reverse primer, 5′-TGCTGGGATTACAGGCGTGAG-3′. Each sample was
subjected to an initial denaturation of 5 min at 95 °C, followed by 15
ampliﬁcation cycles of denaturation at 95 °C for 30 s, annealing at 60 °C
for 40 s and extension at 72 °C for 1 min 30 s. The second round-run,
real-time Taqman PCR was performed on 2.5 μL of the ﬁrst round PCR
product using the forward primer 5′-AGCTTGCCTTGAGTGCTTCAA-3′,
the reverse primer 5′-TGACTAAAAGGGTCTGAGGGATCT-3′ and the
probe 5′-FAM-TTACCAGAGTCACACAACAGACGGGCA-TAMRA-3′.
For each real-time PCR analysis, a standard curve was generated
using dilutions of a representative standard of the amplicon being
measured. No-template controls (no DNA added to the PCR mixture)
and NACs (DNA extracted from cells that were not infected) were run
with each experiment. In each sample RNAse P DNAwas quantiﬁed as
endogenous control and a standard curve for RNAse P was run inparallel. After initial incubations at 50 °C for 2 min and at 95 °C for
10 min, 40 cycles of ampliﬁcation were carried out at 95 °C for 15 s,
followed by 1 min at 60 °C. Reactions were analyzed by using the ABI
Prism model 7700 sequence detection system (Applied Biosystems).
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